Services
Strategy That Drives Execution
Strategy is not a 30-slide deck that nobody opens. It is a single page of explicit choices about what you will and will not do. Every engagement we deliver starts from that principle: clarity first, evidence second, execution always.
Drugs don't make themselves. Their development needs to be financed through personal investment, grants, or investor funds. We help researchers co-create what they need to successfully raise funding and make the right choices along their drug development journey.
Drug Development Strategy
Strategy is an interrelated set of choices required for achieving a goal. We apply proven strategy frameworks from Peter Drucker, Michael Porter, Roger Martin, A.G. Lafley, Renée Mauborgne, and W. Chan Kim into actionable tools for early-stage drug and platform developers. This empowers researchers to build Target Product Profiles and cost-conscious roadmaps for their developments.
Learn more
Target Product Profiles (TPPs)
A TPP defines your product's characteristics and the patient populations it will serve. It guides development activities and explains the drug's features to key stakeholders.
Learn more
Strategy Sprints
These short interactive sessions are designed around one principle: you learn best by doing. In less than 6 hours, teams build their version 1 development strategy and TPP. Leave with tangible outputs that move progress forward.
- EPD-01: Strategy — One framework and one iterative process to kick-start execution.
- EPD-02: TPP — Define your drug characteristics, pressure test your ideas and identify evidence gaps.
Pitch Scrubs
A comprehensive evaluation of your investor or grant deck. We pressure-test your deck, slide-by-slide, and score your pitch investment readiness across 8-10 domains tailored to your stage of development.
- 90-minute slide-by-slide pitch scrub
- Investment readiness score
- Top three strengths, weaknesses, & evidence gaps
- Various packages that match your stage, timeline, and depth of support needed
Project X
Coming soon! One of the biggest challenges in making development choices is feeling like you never have enough information. We want to provide researchers a revolutionary solution to this problem.
Learn moreNot Sure Where to Start?
Book a complimentary 30-minute discovery call. We will review your program, identify the gaps, and recommend a clear path forward.
Most early-stage programs stall because of two bottlenecks: unclear choices and undefined product characteristics. No amount of meetings replaces what deep thinking and brainstorming can do.
Book a Discovery Call